Top Line: Does skin dose influence the risk of developing breast lymphedema after whole breast radiation?
The Study: Breast lymphedema can be relatively common after breast radiation. Obviously disruption of normal breast and axilla lymphatics can influence breast lymphedema risk, but does radiation dose to the skin of the breast also play a role? This study analyzed breast skin dose in 116 patients who received whole breast radiation after breast conservation surgery. Most had undergone sentinel lymph node biopsy (78%), and most received a lumpectomy cavity boost (81%). Just over a third (35%) had oncoplastic surgery. Only 19% received regional nodal irradiation. Moderate hypofractionation was most common (70.7%) followed by conventional fractionation (25%) and ultrahypofractionation (4.3%). Most plans used a field-in-field technique with either static subfields (69%) or sliding window (28.4%). For dosimetric analysis, the skin was defined as the superficial 5mm of the breast. Overall, 24% developed breast lymphedema. On multivariable analysis, skin V40 >90cc and increasing age were significantly associated with breast lymphedema. A challenge here is that V40 is likely at least in part a surrogate for larger breast volume. Yet, superficial dose may be partially modifiable by cropping the target away from the skin surface and using flash or robust optimization rather than virtual bolus to account for breast contour variation during treatment.
TBL: In this study, breast skin V40 >90cc was significantly associated with development of breast lymphedema. | Lasko, Int J Radiat Oncol Biol Phys 2026
The Study: Breast lymphedema can be relatively common after breast radiation. Obviously disruption of normal breast and axilla lymphatics can influence breast lymphedema risk, but does radiation dose to the skin of the breast also play a role? This study analyzed breast skin dose in 116 patients who received whole breast radiation after breast conservation surgery. Most had undergone sentinel lymph node biopsy (78%), and most received a lumpectomy cavity boost (81%). Just over a third (35%) had oncoplastic surgery. Only 19% received regional nodal irradiation. Moderate hypofractionation was most common (70.7%) followed by conventional fractionation (25%) and ultrahypofractionation (4.3%). Most plans used a field-in-field technique with either static subfields (69%) or sliding window (28.4%). For dosimetric analysis, the skin was defined as the superficial 5mm of the breast. Overall, 24% developed breast lymphedema. On multivariable analysis, skin V40 >90cc and increasing age were significantly associated with breast lymphedema. A challenge here is that V40 is likely at least in part a surrogate for larger breast volume. Yet, superficial dose may be partially modifiable by cropping the target away from the skin surface and using flash or robust optimization rather than virtual bolus to account for breast contour variation during treatment.
TBL: In this study, breast skin V40 >90cc was significantly associated with development of breast lymphedema. | Lasko, Int J Radiat Oncol Biol Phys 2026

